Taejoon Pharmaceutical Co., Ltd.

Form 483

Yongin, -, Korea (the Republic of)FEI 3008029795Issued November 15, 2016

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3008029795.

Observations4

Issue DateNovember 15, 2016

StatusNo Warning Letter

Related Inspections3

Establishment Details

Firm: Taejoon Pharmaceutical Co., Ltd.
Location: Yongin, -, Korea (the Republic of)
FEI Number: 3008029795
Product Type: Drugs
Issue Date: November 15, 2016
Country: Korea (the Republic of)

Inspection History, 2016 to 2022

VAI2

OAI1

VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Taejoon Pharmaceutical Co., Ltd. FDA Form 483, Yongin, November 15, 2016